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1. Introduction
   Immune thrombocytopenic purpura (ITP) is a disease with 
an estimated incidence is about 1 in 10 000 children per 
year[1]. In the majority of children, ITP is an acute, generally 
considered a self-limiting benign disorder with a 60%-80% 
change of spontaneous recovery occurring usually within a 
few months after onset[2]. However, the risk of hemorrhagic 
manifestations, especially intracranial hemorrhage (ICH), 
prompts many physicians to consider some form of therapy. 
Causative factors, predictors, and even outcomes of ICH in 
ITP have been difficult to ascertain due to ITP with children 
less than 1% occurrence of this complication[3,4]. Herein, we 
describe a girl who presented with ICH because of unusual 
presentation.
2. Case report
  A 4-year-old girl was admitted to our hospital with 
headache, vomiting bleeding from noise and bruises on 
the extremities for 2 d ago. Her vital signs and physical 
examination were normal with the exception of hemorrhagic 
manifestations. Complete blood counts were as follows: 
hemoglobin 8.6 g/dL, white blood cell count 14 350/
mm³, and platelet count 4 000/mm³. Peripheral blood 
smear showed thrombocytopenia. Aspiration of bone 
marrow showed normal erythroid, myeloid cells and 
megakaryocytes. There were no atypical cells. Cranial 
computerized tomography (CT) revealed hyperdense areas in 
the right occipital regions and bilateral basal ganglia, which 
consisted with hemorrhage (Figures 1). 
  Based on the clinical and laboratory findings, ITP was 
diagnosed and a high-dose methyl prednisone (HDMP) 
treatment (30 mg/kg for 3 d and 20 mg/kg for 4 d), and 
intravenous immunoglobulin (IVIg; 2 g/kg for 2 d) was given. 
Thrombocyte suspension was also infused. On the third day 
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of treatment, thrombocyte count increased to 14 000/mm³, 
headache and vomiting were gradually regressed. On the 
7th day of hospitalization, a thrombocyte count was 57 000/
mm³. The patient discharged from the hospital without any 
neurological sequel on the seventh day of hospitalization.
3. Discussion
  Although it is a rare complication, ICH continues to be the 
most important cause of significant morbidity and mortality 
in ITP[3]. A few studies have examined ICH in children with 
ITP[3]. In a retrospective analysis, the incidence of ICH 
in children with ITP was found as 0.1%–1.0%[5]. Although 
there are no definite predictors of which child will suffer 
an ICH, some factors including history of recent trauma, 
immunization, viral infection, menstruation, drug ingestion, 
adolescents with ITP, systemic lupus erythematosis, retinal 
hemorrhage, ‘wet purpura’ including other severe muco-
cutaneous bleeding, and even cerebral arterio-venous 
malformation may possible be high risk factors predicting 
ICH[1,6,7]. In a retrospective study with ICH twelve patients 
of seventeen cases developed ICH after the onset of ITP 
however five patients had ICH as our cases on presentation. 
In the same series, one patient ingested non-steroidal anti-
inflammatory drug and four patients had a history of head 
trauma[2]. We could not identified any predisposing factor in 
our patient.  
  Platelet counts of less than 20 000/mm³ was generally 
considered risky values for ICH. The threshold platelet count 
for therapy in ITP is not well known because of the lack 
of clinical data; however, ICH in children with ITP is not 
correlated with the severity of bleeding symptoms or with 
the platelet count at onset[6].
  A review between 1975 and 1996 revealed that only 1 of 56 
children with complicated by an ICH had a platelet count of 
more than 20 000/mm3, 73% of patients had a platelet count 
of less than 20 000/mm³[8]. In our patient, platelet counts 
were 4 000/mm³ during ICH. The risk of ICH in patients 
with ITP cannot be accurately assessed. Instead, we must 
concentrate our energy on treating patients intensively in 
whom ICH has occurred. Mortality rate decreased markedly 
owing to these intensive treatment regimens. Because no 
therapeutic approach is predominant, platelet transfusions, 
high-dose steroid and IVIg treatment along with supportive 
care, splenectomy and neurosurgical intervention are 
treatment options[1,7]. Our patient received thrombocyte 
transfusion, high-dose methylprednisolone and IVIg 
treatment. No surgical intervention was thought.
  We suggest that cranial imaging should be performed in 
patients with ITP admitted with bleeding symptoms, vomiting 
and headache even if they had no abnormal neurological 
signs. Secondly, although generally there is no indication 
in ITP without active or severe bleeding, thrombocyte 
transfusions can be used in cases of ICH.
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Figure 1. Hyperdense areas in the right occipital regions and bilateral 
basal ganglia, which consisted with hemorrhage, are shown in A & B.
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